Quoin Pharmaceuticals (QNRX) Receivables - Other (2017 - 2025)
Quoin Pharmaceuticals (QNRX) posted Receivables - Other of $1.4 million for Q3 2025, down 6.67% sequentially from $1.5 million in Q2 2025, and down 17.65% YoY from $1.7 million in Q3 2024.
Quoin Pharmaceuticals (QNRX) Receivables - Other (2017 - 2025) Analysis & Trends
Quoin Pharmaceuticals has reported Receivables - Other for 8 years, with the latest figure at $1.4 million in Q3 2025.
- Quarterly Receivables - Other fell 17.65% year-over-year to $1.4 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $1.4 million (down 17.65% YoY) and the FY2024 annual result came in at $1.7 million, down 15.31% from the prior year.
- Receivables - Other declined to $1.4 million in Q3 2025 per QNRX's latest filing, from $1.5 million in the prior quarter.
- Over five years, Receivables - Other peaked at $2.0 million in Q4 2023 and troughed at $350000.0 in Q2 2021.
- A 4-year average of $1.5 million and a median of $1.7 million in 2024 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2021 and 2025: Receivables - Other increased 26.35% in 2021, then retreated 17.65% in 2025.
- Over 4 years, Receivables - Other stood at $350000.0 in 2021, then jumped by 459.71% to $2.0 million in 2023, then dropped by 15.31% to $1.7 million in 2024, then declined by 15.61% to $1.4 million in 2025.
- According to Business Quant data, Receivables - Other over the past three periods registered $1.4 million, $1.5 million, and $1.6 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Quoin Pharmaceuticals | 491,038.58 | 491,038.58 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.40 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Mar 31, 2025 | 1.60 Mn |
| Mar 31, 2025 | 1.60 Mn |
| Dec 31, 2024 | 1.66 Mn |
| Dec 31, 2024 | 1.66 Mn |
| Sep 30, 2024 | 1.70 Mn |
| Sep 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 1.80 Mn |
| Mar 31, 2024 | 1.90 Mn |
| Mar 31, 2024 | 1.90 Mn |
| Dec 31, 2023 | 1.96 Mn |
| Dec 31, 2023 | 1.96 Mn |
| Jun 30, 2021 | 350,000.00 |
| Jun 30, 2021 | 350,000.00 |
| Dec 31, 2020 | 88,000.00 |
| Dec 31, 2020 | 88,000.00 |